[R01] FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
Ente: National Institute on Aging
Scadenza: 2030-07-31
Importo max: $4,923,453
Paese: US
Descrizione
Project Summary
Alzheimer's disease (AD) is the most common type of dementia characterized by memory impairment and
alteration of diverse cognitive abilities. It is a complex and multifactorial disease involving various genetic and
environmental risk factors that lead to the development of two hallm
Settori: National Institute on Aging
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.